- Post Doctoral Training – Neuroscience, Mayo Clinic College of Medicine
- PhD – Molecular Biology and Microbiology, Case Western Reserve University
- BA – Biochemistry, Connecticut College
Dr. Elizabeth Eckman is the Director of Preclinical Research at MANA. She earned her Ph.D. in Molecular Biology and Microbiology from Case Western Reserve University, where her research focused on novel methods for delivering therapeutic genes and proteins to the mucosal epithelial tissues affected by Cystic Fibrosis. She expanded her training into Neuroscience, conducting postdoctoral research at the Mayo Clinic in Florida. Dr. Eckman was appointed Assistant Professor of Neuroscience at the Mayo Clinic College of Medicine in 2003, and developed a research program focused primarily on Alzheimer’s Disease (AD). Her laboratory continues to research the role of Abeta degradation in AD, as well as the potential of cholinergic agonists to stimulate adult neurogenesis in the regions of the brain most affected by the disease.
Dr. Eckman is enthusiastic about being on the MANA research team, where she can apply her skills to study the complications of prematurity. With substantial expertise in the use of endogenous stem cells to repair damaged tissue, she is designing studies using stem cells to treat various conditions in neonates. She is also applying her knowledge of genetic and biochemical testing to enhance the value of the biobank-stored neonatal samples. Dr. Eckman is particularly interested in neonatal brain ischemia, intraventricular hemorrhage and necrotizing enterocolitis.